HAURAKI PHO
  • Home
  • About us
    • Our People
  • Services We Offer
    • HPHO Practices
    • After Hours Services
    • Breast and Cervical Screening Support
    • Diabetes Management
    • Heart Check
    • Ngā Kaitiaki Manawanui Whai Ora
    • Outreach Immunisation Service
    • Primary Options
    • Patient Portal
    • Primary Mental Health Services
    • Shared Electronic Health Record
  • News & Support
    • Education and Training
    • Coronavirus Updates >
      • COVID-19 Vaccine Updates
    • Join the Team!
  • Hauraki Locality
  • Contact
  • Home
  • About us
    • Our People
  • Services We Offer
    • HPHO Practices
    • After Hours Services
    • Breast and Cervical Screening Support
    • Diabetes Management
    • Heart Check
    • Ngā Kaitiaki Manawanui Whai Ora
    • Outreach Immunisation Service
    • Primary Options
    • Patient Portal
    • Primary Mental Health Services
    • Shared Electronic Health Record
  • News & Support
    • Education and Training
    • Coronavirus Updates >
      • COVID-19 Vaccine Updates
    • Join the Team!
  • Hauraki Locality
  • Contact

COVID-19 VACCINE UPDATES

Use of Nuvaxovid as second booster

17/7/2022

 
​The fourth dose / second booster dose of Novavax's COVID-19 vaccine Nuvaxovid may now be administered without prescription to:
  • any person aged 50 years and over;
  • residents of aged care and disability care facilities, aged 18 years and over
  • severely immunocompromised people who receive a three-dose primary course and a fourth dose as a first booster (noting this would be the fifth dose for these people), aged 18 years and over;
  • people aged 18 years and over who have a medical condition that increases the risk of severe breakthrough COVID-19 illness
  • disabled people aged 18 years and over with significant or complex health needs or multiple comorbidities which increase the risk of poor outcomes from COVID-19;
  • healthcare workers, including disability workers and aged care workers, aged 30 years and over.
The fourth dose / second booster dose can be administered at least 6 months from the last dose of a COVID-19 vaccine. 

This use of Nuvaxovid has been authorised by the Director General of Health


Comments are closed.

    Author

    Write something about yourself. No need to be fancy, just an overview.

    Archives

    August 2022
    July 2022
    March 2022
    February 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    April 2021
    March 2021
    February 2021

    Categories

    All

    RSS Feed

THAMES
106 Sealey Street, Thames 3500
phone 07-868-9686
Send us a message
HAMILTON
​18 Karewa Place ,Pukete
​Hamilton 3200

phone 07-868-9686
Send us a message
Picture
Copyright © Hauraki Primary Health Organisation  |  2020